Knowledge of bladder cancer risk factors among patients diagnosed with non-muscle invasive bladder cancer

No AccessJournal of UrologyJU Forum1 Jan 2023Knowledge of Bladder Cancer Risk Factors Among Patients Diagnosed With Nonmuscle-invasive Bladder Cancer Richard S. Matulewicz, Karissa Whiting, Bernard H. Bochner, Jamie S. Ostroff, and Helena Furberg Richard S. MatulewiczRichard S. Matulewicz *Correspondence: Memorial Sloan Kettering Cancer Center, 353 E 68th St #524, New York, New York 10016 telephone: 646-422-4874; E-mail Address: [email protected] Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Karissa WhitingKarissa Whiting Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Bernard H. BochnerBernard H. Bochner Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , Jamie S. OstroffJamie S. Ostroff Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author , and Helena FurbergHelena Furberg Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002978AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1. . Smoking and bladder cancer: a systematic review of risk and outcomes. Eur Urol Focus. 2015; 1(1):17-27. Google Scholar 2. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol. 2013; 63(4):724-732. Google Scholar 3. . Prevalence and correlates of successful smoking cessation in bladder cancer survivors. Urology. 2021; 153:236-243. Google Scholar 4. Association of biochemically verified post-diagnosis smoking and nonmuscle-invasive bladder cancer recurrence risk. J Urol. 2022; 207(6):1200-1206. Link, Google Scholar 5. . Perceptions of the link between smoking and bladder cancer among United States adults. J Urol. 2021; 205(2):324-326. Link, Google Scholar 6. Awareness of smoking as a risk factor in bladder cancer: results from the prospective FinnBladder 9 trial. Eur Urol Focus. 2022;S2405-4569(22)00035-9. Google Scholar 7. . Are patients aware of the association between smoking and bladder cancer?J Urol. 2006; 176(6 pt 1):2405-2408. Abstract, Google Scholar 8. . Patient awareness of smoking as a risk factor for bladder cancer. Int Urol Nephrol. 2010; 42(2):309-314. Google Scholar 9. . Effective cessation treatment for patients with cancer who smoke-the fourth pillar of cancer care. JAMA Netw Open. 2019; 2(9):e1912264. Google Scholar 10. . Assessment of tobacco screening and smoking cessation recommendations among bladder cancer guidelines: a call to action. J Urol. 2022; 207(3):490-492. Google Scholar Submitted August 15, 2022; accepted September 12, 2022; published October 4, 2022. Support: American Cancer Society Grant # RSG-14-167-01 (Furberg), NCI # P30 CA008748 (MSKCC Core Grant), and NCI # K08 CA259452-01A1 (Matulewicz). Conflict of Interest: BHB: Olympus. Ethics Statement: This study received Institutional Review Board approval (IRB No. 15-047). © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue 1January 2023Page: 6-8 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.Keywordsurinary bladder neoplasmssmokingcotinineAcknowledgmentsWe thank Stacey Petruzella and Jessica Carruthers for their contributions to this study and manuscript.MetricsAuthor Information Richard S. Matulewicz Memorial Sloan Kettering Cancer Center, New York, New York *Correspondence: Memorial Sloan Kettering Cancer Center, 353 E 68th St #524, New York, New York 10016 telephone: 646-422-4874; E-mail Address: [email protected] More articles by this author Karissa Whiting Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Bernard H. Bochner Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Jamie S. Ostroff Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Helena Furberg Memorial Sloan Kettering Cancer Center, New York, New York More articles by this author Expand All Submitted August 15, 2022; accepted September 12, 2022; published October 4, 2022. Support: American Cancer Society Grant # RSG-14-167-01 (Furberg), NCI # P30 CA008748 (MSKCC Core Grant), and NCI # K08 CA259452-01A1 (Matulewicz). Conflict of Interest: BHB: Olympus. Ethics Statement: This study received Institutional Review Board approval (IRB No. 15-047). Advertisement PDF downloadLoading ...